Does MOBOCERTINIB Cause Lung neoplasm malignant? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Lung neoplasm malignant have been filed in association with MOBOCERTINIB. This represents 10.4% of all adverse event reports for MOBOCERTINIB.
74
Reports of Lung neoplasm malignant with MOBOCERTINIB
10.4%
of all MOBOCERTINIB reports
32
Deaths
14
Hospitalizations
How Dangerous Is Lung neoplasm malignant From MOBOCERTINIB?
Of the 74 reports, 32 (43.2%) resulted in death, 14 (18.9%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOBOCERTINIB. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does MOBOCERTINIB Cause?
Diarrhoea (309)
Death (160)
Rash (106)
Non-small cell lung cancer (96)
Nausea (85)
Decreased appetite (80)
Vomiting (74)
Fatigue (66)
Asthenia (56)
Weight decreased (54)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which MOBOCERTINIB Alternatives Have Lower Lung neoplasm malignant Risk?
MOBOCERTINIB vs MOCLOBEMIDE
MOBOCERTINIB vs MODAFINIL
MOBOCERTINIB vs MOGAMULIZUMAB
MOBOCERTINIB vs MOGAMULIZUMAB-KPKC
MOBOCERTINIB vs MOLNUPIRAVIR